Atlas Trials

Evaluation of the Relationship of TOP2α Expression and Effect of Non Dose-dense Chemotherapy for Breast Cancer

Clinical trial NCT02506361 · UNKNOWN

Trial details

NCT number
NCT02506361
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Breast Cancer
Start date
2015-05-01
Primary completion
2025-05-01
Enrollment
800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.